Aerogen, a global leader in acute-care aerosol drug delivery solutions, has launched its India headquarters in the National Capital Territory of Delhi. Ireland’s Minister for Higher Education, Research, and Innovation, James Lawless, inaugurated the office during his visit to India on St. Patrick’s Day.
Enhancing Access to Aerosol Drug Delivery in India
With over 55 million Indians affected by chronic obstructive pulmonary disease (COPD) and an increasing burden of respiratory illnesses, Aerogen aims to improve access to its advanced vibrating mesh nebulizer technology. Already in use across Europe and the USA, this technology is set to support Indian healthcare providers in delivering better respiratory care.
Strengthening India-Ireland Collaboration in Healthcare
Speaking at the inauguration, Minister James Lawless emphasized the significance of this expansion in strengthening the healthcare ties between India and Ireland. “This milestone reinforces our shared commitment to healthcare innovation. Aerogen’s decision to establish a presence in India reflects the country’s rapidly evolving healthcare ecosystem. We look forward to fostering cross-border collaborations that benefit both nations,” he stated.
Building a Strong Local Team
Aerogen’s India headquarters will serve as the operational hub for its growing team. The company is starting with 14 employees and plans to expand to 30 within the next five years. The team will include a country director, marketing professionals, commercial sales specialists, and clinical experts to drive Aerogen’s mission in India.
Commitment to Supporting India’s Healthcare System
Hannah Yuill, Senior Commercial Director APAC at Aerogen, highlighted the company’s commitment to improving respiratory care. “Aerogen is dedicated to ensuring that hospitals and patients in India have access to cutting-edge aerosol drug delivery systems. With India’s large population and rising respiratory health challenges, this expansion is crucial for strengthening the healthcare system. It also ensures safe and effective patient care. Our investment in India is a key part of our strategy to grow in the APAC region and collaborate closely with healthcare professionals,” she said.
Enterprise Ireland’s Role in Aerogen’s Expansion
As reported by expresspharma, Enterprise Ireland, the Irish government agency that supports international business expansion, has played a crucial role in Aerogen’s global growth. Ross Curran, Director – India & South Asia, Enterprise Ireland, emphasized Ireland’s leadership in medtech innovation. “Ireland is a global leader in medical technology, and Aerogen is at the forefront of this advancement. Their expansion in India reflects their commitment to improving respiratory care worldwide. It also strengthens economic and business collaborations between Ireland and India. We are proud to support Aerogen in making a lasting impact on global healthcare,” he said.
Investing in Research, Partnerships, and Training
Aerogen’s presence in India is expected to boost investment in research, foster collaborations, and introduce training programs for healthcare professionals. The company collaborates with clinicians, hospitals, and channel partners across India and Sri Lanka. It aims to accelerate the adoption of its aerosol drug delivery technology and strengthen India’s healthcare infrastructure.